HI
LABU icon

Hoey Investments’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Hoey Investments’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-190
Closed -$30.3K – 436
2025
Q4 		$30.3K Hold
190
– – ﹤0.01% 189
2025
Q3 		$17.8K Hold
190
– – ﹤0.01% 223
2025
Q2 		$10.8K Hold
190
– – ﹤0.01% 235
2025
Q1 		$11.6K Hold
190
– – ﹤0.01% 207
2024
Q4 		$17.1K Hold
190
– – ﹤0.01% 184
2024
Q3 		$21.6K Hold
190
– – ﹤0.01% 167
2024
Q2 		$21.6K Hold
190
– – ﹤0.01% 167
2024
Q1 		$25.2K Hold
190
– – 0.01% 157
2023
Q4 		$23.2K Hold
190
– – 0.01% 160
2023
Q3 		$14.5K Hold
190
– – ﹤0.01% 185
2023
Q2 		$22.5K Buy
190
+125
+192% +$15.6K 0.01% 167
2023
Q1 		$6.38K Hold
65
– – ﹤0.01% 237
2022
Q4 		$9.19K Hold
65
– – ﹤0.01% 219
2022
Q3 		$9K Buy
+65
New +$11.9K ﹤0.01% 235

Other funds holding LABU

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $885M AUM 47.78% 1-Year Est. Return
Belvedere Trading
Belvedere Trading Chicago, Illinois $84.4B AUM 52.68% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Hoey Investments's LABU Position: Q1 2026 in Review

Hoey Investments sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2026, closing a stake of 190 shares — an estimated $30.3K sold.

Hoey Investments first reported a position in LABU in Q3 2022 and held it in 14 quarters. The position peaked at $30.3K in Q4 2025. 33 funds tracked by Wall St. Rank hold LABU as of Q1 2026.

  • Hoey Investments reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q1 2026 after selling out during the quarter.
  • Hoey Investments sold 190 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2026, an estimated $30.3K.
  • Hoey Investments first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2022 and held it in 14 quarters.
  • Hoey Investments's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $30.3K in Q4 2025.
  • 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2026.

Based on Hoey Investments's 13F filing for Q1 2026, filed 29 Apr 2026.